Western Wealth Management LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 9,219 shares of the company’s stock, valued at approximately $1,185,000.
A number of other institutional investors have also added to or reduced their stakes in the company. Invst LLC bought a new position in shares of Merck KGaA in the second quarter valued at approximately $302,000. First Bancorp Inc ME purchased a new position in shares of Merck KGaA in the 2nd quarter worth about $708,000. Roberts Glore & Co. Inc. IL purchased a new stake in Merck KGaA during the second quarter worth about $776,000. Jupiter Topco LLC bought a new stake in Merck KGaA in the second quarter worth about $501,199,000. Finally, ADAR1 Capital Management LLC purchased a new position in Merck KGaA in the second quarter valued at about $403,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Stock Up 0.3%
Merck KGaA stock opened at $164.00 on Wednesday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $21.20 billion, a P/E ratio of 25.04 and a beta of 0.96. The firm has a 50 day moving average price of $163.08 and a 200-day moving average price of $148.69. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
